""

Hepatobiliary tumors

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

Title: Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial)
Phase: III
Contact: Margit Peters-Hornig / (Kontaktperson)
Email-Address: Margit.Peters-Hornig@med.uni-heidelberg.de
Clinical Investigator: Prof. Dr.Dr.Christoph Springfeld
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT02170090
EudraCT-Number: siehe EU klinisches Studienregister 2012-005078-70

Surgical Study

There are currently no studies available

Radiotherapy Study

Title: Phase I study evaluating the treatment of patients with advanced hepatocellular carcinoma (HCC) with Carbon Ion Radiotherapy
Phase: I
Contact: Karen Lossner / (Kontaktperson)
Email-Address: karen.lossner@med.uni-heidelberg.de
Clinical Investigator: Prof. Dr.Dr.rer.nat. Jürgen Debus
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT01167374
EudraCT-Number: siehe EU klinisches Studienregister 2010-018328-23

Metastatic Disease: First-Line-Therapy

Title: A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib Versus Gemcitabine With Cisplatin in Subjects With Advanced/Metastatic or Inoperable Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations
Phase: III
Contact: Ulrike Lauterbach / (Study Nurse)
Email-Address: Ulrike.Lauterbach@med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. Karl-Heinz Weiss
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT03773302
EudraCT-Number: siehe EU klinisches Studienregister 2018-004004-19

Metastatic Disease: Follow-Up Care

Title: A Phase II Multicenter, Single Arm Study of Oral BGJ398 in Adult Patients With Advanced or Metastatic Cholangiocarcinoma With FGFR2 Gene Fusions or Other FGFR Genetic Alterations Who Failed or Are Intolerant to Platinum-based Chemotherapy
Phase: II
Contact: Elisabeth Lawrence / (Study Nurse)
Email-Address: Elisabeth.Lawrence@med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. Karl-Heinz Weiss
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT02150967
EudraCT-Number: siehe EU klinisches Studienregister 2013-005085-19

Other study

There are currently no studies available